Home > Insider Trading > Filing (0000950103-21-009692)

Filing Details

Accession Number:: 0000950103-21-009692
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-29 20:31:11
Reporting Period:: 2021-06-25

Accepted Time:: 2021-06-29 20:31:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1802768	Royalty Pharma Plc	RPRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1016835	B Rory Riggs	C/O Royalty Pharma Plc 110 E. 59Th Street New York NY 10022		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Ordinary Shares	Disposition	2021-06-25	179,100	$42.81	933,910	No	4	S	Indirect	By New Ventures Select
Class A Ordinary Shares	Disposition	2021-06-25	487,364	$42.69	4,099,706	No	4	S	Indirect	By New Ventures I LLC
Class A Ordinary Shares	Disposition	2021-06-28	167,448	$42.11	3,932,258	No	4	S	Indirect	By New Ventures I LLC
Class A Ordinary Shares	Disposition	2021-06-29	1,200	$42.01	3,931,058	No	4	S	Indirect	By New Ventures I LLC
Class A Ordinary Shares	Disposition	2021-06-29	479,800	$41.26	3,451,258	No	4	S	Indirect	By New Ventures I LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By New Ventures Select
No	4	S	Indirect	By New Ventures I LLC
No	4	S	Indirect	By New Ventures I LLC
No	4	S	Indirect	By New Ventures I LLC
No	4	S	Indirect	By New Ventures I LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Ordinary Shares	679,760	Direct
Class A Ordinary Shares	2,081,540	Indirect	By New Ventures III LLC
Class A Ordinary Shares	15,000	Indirect	By Spouse

Footnotes

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.44 to $43.29 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.33 to $43.04 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.90 to $42.79 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.87 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.